References

PRACTITIONER | HOME

1. VTI Data on file, 2015. N=59. Data assessed after 1 week of wear. Preference based on those who expressed a preference among brands tested.
2. Cooper J, O’Connor B, Watanabe R, Fuerst R, Berger S, Eisenberg N, Dillehay SM. (2018). Case series analysis of myopic progression control with a unique extended depth of focus multifocal contact lens. Eye & Contact Lens, 4(5): e16- e24.doi:10.1097/ICL.0000000000000440
3. Patents Awarded – MULTIFOCAL OPHTHALMIC LENS WITH INDUCED APERTURE. See htts://vtivision.com/about/patents/ for patent numbers.

 

PRACTITIONER | LENS DESIGN

1. VTI data on file, 2015. n=59. Data assessed after 1 week of wear; vs. other traditional (lenses with two focal points) studied.
2. Chima AS, Formankiewicz MA, Waugh SJ. Investigation of interocular blur suppression using luminance-modulated and contrast-modulated noise stimuli. J Vis. 2015 Mar 26;15(3):22. doi: 10.1167/15.3.22. PMID: 25814548.
3. Maiello G, Walker L, Bex PJ, Vera-Diaz FA. Blur perception throughout the visual field in myopia and emmetropia. J Vis. 2017 May 1;17(5):3. doi: 10.1167/17.5.3. PMID: 28476060; PMCID: PMC5425112.

 

PRACTITIONER | MULTIFOCAL PRESBYOPIA TREATMENT

1. VTI data on file, 2015. n=59. Data assessed after 1 week of wear; vs. other traditional (lenses with two focal points) studied.
2. Chima AS, Formankiewicz MA, Waugh SJ. Investigation of interocular blur suppression using luminance-modulated and contrast-modulated noise stimuli. J Vis. 2015 Mar 26;15(3):22. doi: 10.1167/15.3.22. PMID: 25814548.
3. Maiello G, Walker L, Bex PJ, Vera-Diaz FA. Blur perception throughout the visual field in myopia and emmetropia. J Vis. 2017 May 1;17(5):3. doi: 10.1167/17.5.3. PMID: 28476060; PMCID: PMC5425112.

 

PRACTITIONER | MULTIFOCAL MYOPIA MANAGEMENT

1. Patents Awarded – MULTIFOCAL OPHTHALMIC LENS WITH INDUCED APERTURE. See https://vtivision.com/about/patents/ for patent numbers.
2. Huang J, et al. (2016) Effi cacy Comparison of 16 Interventions for Myopia Control in Children. Ophthalmology. 123(4): 697-708.
3. Holden, B.A., et al. (2016) Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology, 123(5): 1036-1042
4. Flitcroft, D. (2012). The complex interactions of retinal, optical and environmental factors in myopia aetiology. Progress in Retinal and Eye Research, 31(6): 622-660.
5. Bullimore MA, Brennan NA. Myopia Control: Why Each Diopter Matters. Optom Vis Sci. 2019 Jun; 96(6):463-465
6. Dillehay S, Woods J, Situ P, Payor R, Griffi n R, Tyson M, Jones L. (2014). Comparison of Three Power Levels of a Novel Soft Contact Lens Optical Design to Reduce Suspected Risk Factors for the Progression of Juvenile Onset Myopia. ARVO Poster, Poster #A00863637; Investigative Ophthalmology & Visual Science. 55(13). 3637
7. Payor R, Woods J, Situ P, Dillehay S, Griffi n R, Tyson M, & Jones L. (2014) Feasibility Testing of a Novel SCL Optical Design to Reduce Suspected Risk Factors for the Progression of Juvenile Onset Myopia. Investigative Ophthalmology & Visual Science. 55(13). 3638. Retrieved from http://iovs.arvojournals.org/article.aspx?articleid=2269075.
8. Cooper J, O’Connor B, Watanabe R, Fuerst R, Berger S, Eisenberg N, Dillehay SM. (2018). Case series analysis of myopic progression control with a unique extended depth of focus multifocal contact lens. Eye & Contact Lens, 4(5): e16- e24.doi:10.1097/ICL.0000000000000440
9. VTI data on file. N=59. Data assessed after 1 week of wear.

 

PRACTITIONER | QUICKSTART CALCULATOR

1. The NaturalVue® Multifocal QuickStart Calculator is available at www.naturalvuecalculator.com, or as an app from the Apple® App Store® and Google Play. Google Play and the Google Play logo are trademarks of Google Inc. Apple and the Apple logo are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc.

 

NATURALVUE® INDICATIONS FOR USE
NaturalVue® (etafilcon A) Multifocal 1 Day Disposable Soft Contact Lenses are indicated for daily wear for the correction of refractive ametropia (myopia and hyperopia), and/or presbyopia, and myopia progression control in normal eyes.